|
|
|
Half year to 31 Mar 10 |
Half year to 31 Mar 09 |
Year to 30 Sep 09 |
|
|
|
Note |
(Unaudited) £’000 |
(Unaudited) £’000 |
(Audited) £’000 |
|
|
Cash flows from operating activities |
|
|
|
||
|
Cash generated from continuing operating activities prior to the effect of exceptional items |
|
4,919 |
3,903 |
7,449 |
|
|
Cash effect of exceptional items |
|
(848) |
(784) |
(1,688) |
|
|
Cash generated from continuing operations |
|
4,071 |
3,119 |
5,761 |
|
|
Cash used in discontinued operations |
|
(854) |
(1,152) |
(2,614) |
|
|
Cash generated from operations |
|
3,217 |
1,967 |
3,147 |
|
|
Finance income received |
|
7 |
2 |
33 |
|
|
Finance costs paid |
|
(420) |
(735) |
(1,582) |
|
|
Tax received/(paid) |
|
23 |
(465) |
(282) |
|
|
Net cash generated from operating activities |
|
2,827 |
769 |
1,316 |
|
|
Cash flows from investing activities |
|
|
|
|
|
|
Proceeds from sale of operations |
|
- |
2,050 |
2,050 |
|
|
Acquisition of subsidiaries – deferred consideration |
|
(126) |
- |
- |
|
|
Proceeds from sale of property, plant and equipment |
|
- |
1,404 |
4,798 |
|
|
Purchase of property, plant and equipment |
|
(2,699) |
(1,287) |
(2,684) |
|
|
Purchase of intangible assets |
|
(99) |
(153) |
(884) |
|
|
Net cash (used in)/generated from investing activities |
(2,924) |
2,014 |
3,280 |
||
|
Cash flows from financing activities |
|
|
|
|
|
|
Net movements in loans |
|
(2,590) |
(4,305) |
(6,005) |
|
|
Dividends paid to minority shareholders |
|
(142) |
- |
(283) |
|
|
Purchase of own shares |
|
(13) |
- |
- |
|
|
Net cash used in financing activities |
|
(2,745) |
(4,305) |
(6,288) |
|
|
Net decrease in cash, cash equivalents and bank overdrafts |
(2,842) |
(1,522) |
(1,692) |
||
|
Cash, cash equivalents and bank overdrafts at beginning of the period |
(1,090) |
414 |
414 |
||
|
Effects of exchange rate changes |
|
(167) |
45 |
188 |
|
|
Cash, cash equivalents and bank overdrafts at end of the period |
|
(4,099) |
(1,063) |
(1,090) |
|